| Literature DB >> 33256207 |
Roxana Ghiulai1, Oana Janina Roşca1, Diana Simona Antal2, Marius Mioc1, Alexandra Mioc3, Roxana Racoviceanu1, Ioana Macaşoi4, Tudor Olariu5, Cristina Dehelean4, Octavian Marius Creţu6, Mirela Voicu7, Codruţa Şoica1.
Abstract
Wounds are among the most common skin conditions, displaying a large etiological diversity and being characterized by different degrees of severity. Wound healing is a complex process that involves multiple steps such as inflammation, proliferation and maturation and ends with scar formation. Since ancient times, a widely used option for treating skin wounds are plant- based treatments which currently have become the subject of modern pharmaceutical formulations. Triterpenes with tetracyclic and pentacyclic structure are extensively studied for their implication in wound healing as well as to determine their molecular mechanisms of action. The current review aims to summarize the main results of in vitro, in vivo and clinical studies conducted on lupane, ursane, oleanane, dammarane, lanostane and cycloartane type triterpenes as potential wound healing treatments.Entities:
Keywords: pentacyclic triterpenes; tetracyclic triterpenes; wound healing
Mesh:
Substances:
Year: 2020 PMID: 33256207 PMCID: PMC7730621 DOI: 10.3390/molecules25235557
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Skin structure.
Figure 2Healing cascade phases of acute wounds.
Figure 3Chemical structures of lupane-skeleton triterpenes.
Figure 4Chemical structures of ursane-skeleton triterpenes.
Figure 5Chemical structures of oleanane-skeleton triterpenes A.
Figure 6Chemical structures of oleanane-skeleton triterpenes B.
Figure 7Key structural features present in all pentacyclic triterpene structures with wound healing properties (A); superimposed 3D structures of wound healing pentacyclic triterpene structures (B); areas where key functional groups appear are highlighted in yellow; structures that have glycosylated OH or COOH groups, are depicted only as triterpene scaffolds for better image clarity.
Figure 8Chemical structures of dammarane-type triterpenes.
Figure 9Chemical structure of cycloastragenol, a lanostane-type triterpenes.
Figure 10Chemical structure of cycloartane-type triterpenes.
Triterpenoids with in vitro wound healing effects.
| Phytocompound | Source | In vitro Method/Model | Biological Activity | Reference |
|---|---|---|---|---|
|
|
| Lipid peroxidation test/egg yolk | Protection against lipid peroxidation | [ |
|
| Lipopolysaccharide-stimulated RAW264.7 macrophages | HO-1/Nrf2 translocation suppressing the NF-κB pathway | [ | |
| Pure | Rat cardiomyocyte-derived H9c2 cell/hypoxia/reoxygenation (H/R) model | Protection against myocardial ischemia reperfusion injury | [ | |
|
| Birch bark | Human keratinocytes | Keratinocyte migration, increase of pro-inflammatory mediators | [ |
|
| Epidermal keratinocytes and dermal fibroblasts/scratch wound healing assay | Enhancement in migration and wound closure and | [ | |
|
| Pure | Human dermal fibroblasts, human epidermal | increased migration rates of skin cells; enhance the initial skin cell adhesion; increase in the number of normal human dermal fibroblasts | [ |
| Pure | Human dermal fibroblasts | Increases the synthesis of type I collagen by activation of the Smad pathway | [ | |
|
| HaCaT keratinocytes | Pro-migratory effect; upregulation of signaling pathways involved in wound healing:FAK, Akt, and MAPK | [ | |
| Pure | Keloid primary fibroblast cultures | Inhibition of keloid fibroblasts proliferation and prevention of excessive scarring | [ | |
|
| Pure | Primary keloid and normal fibroblasts | Keloid prevention by inhibiting TGF-β1-induced collagen expression via PPAR-γ activation | [ |
|
|
| NIH/3T3 | Enhanced wound closure by stimulation of the migration of fibroblasts | [ |
| Pure | mink lung epithelial cells, MDA-MB-231 | Stimulation of cell migration by stimulation of mitogen-activated protein (MAP) kinases | [ | |
|
| Pure | Normal human dermal fibroblasts | Reduction of fibrosis, increase of apoptosis and reduction of autophagy in keloids by HMGB1 inhibition | [ |
|
|
| Normal human neonatal skin | Enhanced proliferation | [ |
|
|
| Normal human dermal fibroblasts | Promotion of collagen synthesis | [ |
|
| Human dermal fibroblast cells | Healing effect, increase in type I collagen synthesis by activating the Smad pathway | [ | |
| Pure | HaCaT/wound scratch assay | Wound healing stimulation by increasing the migration of human keratinocytes through S1P dependent mechanism. | [ | |
|
|
| Human HaCaT keratinocytes and primary human dermal fibroblasts/Scratch wound test | Increase cell migration and proliferation by EGFR stimulation | [ |
| Pure | Human epidermal stem cells EpSCs | Wound healing by stimulation of EPSCS proliferation and migration by activation of Wnt/β-catenin signaling | [ | |
|
| Pure | human keratinocytes/migration scratch assay | Wound healing by proliferation and migration | [ |
|
|
| Human HaCaT keratinocytes and primary human dermal fibroblasts | Stimulation of skin cell proliferation and migration by activation of EGFR, | [ |
Triterpenoids with in vivo wound healing effects.
| Phytocompound | Source | In Vivo Method/Model | Biological Activity | Reference |
|---|---|---|---|---|
|
| ||||
|
| Birch bark | Pig ear/porcine ex vivo excision wound healing model and re-epithelialization | Formation of the skin barrier, wound healing, re-epithelization | [ |
|
|
| Male Wistar rats/streptozotocin | Enhancement of the healing process through the anti-inflammatory effect of NF- | [ |
|
|
| Rabbits/excision wound | Shortening of the epithelization period by increase in hydroxyproline content and induction of collagen synthesis | [ |
| Pure | Rabbits/excision wound | Accelerated wound healing, keloid prevention formation, invisible scar formation in open wounds showing tissue loss | [ | |
| Pure | Guinea pigs/excision wound | Enhanced rate of wound healing | [ | |
|
|
| Male mice/excision wound | Enhanced cicatrizant activity | [ |
|
|
| Swiss Wistar strain rats/incision wound models | Acceleration of epithelialization and wound contraction rate | [ |
|
| Pure | Sprague–Dawley male rats/incision wound model | Wound healing by enhanced cell density, regularly organized dermis and angiogenesis | [ |
|
| Pure | Sprague-Dawley (SD) female rats/excision model | Faster wound closure by increased collagen synthesis and TGF-β1 levels | [ |
| Pure | Sprague–Dawle female rat/skin excision wound model | Acceleration of the wound re-epthelization, angiogenesis, scar prevention | [ | |
|
| ||||
|
|
| Male Balb/c mice/burn wound model | Increase in burn wound repair by | [ |
| Pure | Sprague-Dawley rats/burn wound model | Accelerated skin recovery in deep partial-thickness burn injury by VEGF prodiuction | [ | |
|
|
| Male ICR mice/burn wound model | Accelerated burn wound healing by increased antioxidative | [ |
| Pure | Male Sprague-Dawley rats/burn wound model | Accelerated burn wound healing, wound contraction by stimulation of collagen synthesis, reducing oxidative stress and inducing vasodilatation | [ | |
| Pure | SD rats/burn wound model | Scar reduction and wound healing improvement | [ | |
|
| Pure | BALB/c mice/burn wound model | Restores the synthesis of β-defensins and enhances the resistance to infection with | [ |
| Pure | Male Sprague-Dawley rats/thermal injury model | Anti-inflammatory effect and organ protection by inhibition of HMGB1 | [ | |
|
| Male Balb/c mice/burn wound model | Reduction of wound area, enhanced wound healing by increased neovascularization and VEGF production | [ | |
|
| Pure | New Zealand Albino rabbits/thermal injury model | Reduction of the scarring area and scarring thickness by downregulation of MMP-1 or TGF-β1 proteins | [ |
|
| ||||
|
| Pure | Male C57BL/6 mice/random-pattern skin flap model | Promotion of angiogenesis, reduction of tissue edema, increase in the survivability of the skin flap | [ |
|
| Pure | Male Sprague–Dawley rats/experimental model of rat skin flaps | Enhancement in microcirculation and viability of the skin flaps | [ |
|
| ||||
|
| Pure | SPF SD male rats/diabetic wound model | Accelerated healing of diabetic cutaneous ulcers by regulating Wnt/β-Catenin signaling pathway | [ |
| Pure | Sprague Dawley male | Enhanced rate of wound healing | [ | |
|
| ||||
|
|
| Male Swiss Albino mice/induced gastric ulcer model | Gastroprotective effect | [ |
|
| Male Sprague–Dawley rats/induced gastric ulcer model | Regeneration of the lesions, increase in gastric mucosal thickness | [ | |
|
| ||||
|
|
| Male C57BL/6JNarl mice/infected wound healing | Wound healing activity by stimulation of angiogenesis | [ |
|
|
| Male C57BL/6JNarl mice/infected wounds | Promotion of cutaneous wound healing by enhanced angiogenesis | [ |
|
| ||||
|
|
| Ultraviolet induced psoriasis-like wounds/male albino Wistar rats | Accelerated healing process | [ |
|
| ||||
|
| Pure | ICR mice/hind | Anti-inflammatory activities, pain relief by inhibition of iNOS, COX-2, interleukin-6, IL-1 | [ |
|
| ||||
|
| Pure | Male Sprague Dawley rats exposed to LPS/aortic contraction-realaxation in sepsis | Reduction in impairments of aortic contraction; antiinflamatory effect | [ |